Paralyzed Patients Regain Movement in Stem Cell Trial: Is It Too Early to Celebrate? – KQED
KQED |
Paralyzed Patients Regain Movement in Stem Cell Trial: Is It Too Early to Celebrate?
KQED The trial is injecting oligodendrocyte progenitor cells, produced from human embryonic stem cells, into patients ages 18-69. These trial subjects have suffered recent spinal cord injuries in the neck, resulting in the loss of nearly all sensation and … |
